Design & Preclinical Evaluation of Degrader Antibody Conjugates
Time: 2:00 pm
day: Day One
Details:
- Optimization of linker payload
- A demonstration of targeted protein degradation in vitro
- Preclinical efficacy observed with antibodies targeting multiple tumor associated antigens in xenograft models
